Z. Debebe

发表

Endothelin-1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia.

S. Nekhai, O. Castro, J. Prchal, 2006, Haematologica.

Distinct clinical and immunologic profiles in severe malarial anemia and cerebral malaria in Zambia.

S. Nekhai, R. Bucala, V. Gordeuk, 2011, The Journal of infectious diseases.

Elevated homocysteine, glutathione and cysteinylglycine concentrations in patients homozygous for the Chuvash polycythemia VHL mutation

Tatiana Ammosova, S. Nekhai, J. Prchal, 2008, Haematologica.

Cancer Poised State of Wnt Signaling in Renal Receptor 2 ( Ror 2 ) Expression Creates a Receptor Tyrosine Kinase-like Orphan Molecular Bases of Disease :

G. Wahl, W. Rathmell, M. B. Major, 2013 .

Receptor Tyrosine Kinase-like Orphan Receptor 2 (Ror2) Expression Creates a Poised State of Wnt Signaling in Renal Cancer*

G. Wahl, W. Rathmell, M. B. Major, 2013, The Journal of Biological Chemistry.

Ferroportin (SLC40A1) Q248H mutation is associated with lower circulating plasma tumor necrosis factor-alpha and macrophage migration inhibitory factor concentrations in African children.

S. Nekhai, V. Gordeuk, I. Kasvosve, 2010, Clinica chimica acta; international journal of clinical chemistry.

Ferroportin Q248h, dietary iron, and serum ferritin in community African-Americans with low to high alcohol consumption.

S. Nekhai, V. Gordeuk, H. Tsukamoto, 2008, Alcoholism, clinical and experimental research.

Iron chelators ICL670 and 311 inhibit HIV-1 transcription.

S. Nekhai, D. Richardson, V. Gordeuk, 2007, Virology.

Development of a sensitive HPLC method to measure in vitro permeability of E- and Z-isomeric forms of thiosemicarbazones in Caco-2 monolayers.

S. Nekhai, D. Richardson, V. Gordeuk, 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Ror2 as a therapeutic target in cancer.

W. Rathmell, Z. Debebe, 2015, Pharmacology & therapeutics.

Expression of Ror2 Mediates Invasive Phenotypes in Renal Cell Carcinoma

E. Wallen, A. Hakimi, J. Hsieh, 2014, PloS one.

Dephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-1 in Tat-activated HIV-1 transcription

S. Nekhai, J. Brady, K. Washington, 2005, Retrovirology.

Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection.

V. A. Stewart, W. Ballou, Joe D. Cohen, 2009, The Journal of infectious diseases.

Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9

S. Nekhai, F. Kashanchi, D. Richardson, 2011, Molecular Pharmacology.

Enrichment of adeno-associated virus serotype 5 full capsids by anion exchange chromatography with dual salt elution gradients.

Z. Debebe, Eric J. Yearley, A. Tracy, 2023, Biotechnology and bioengineering.

Iron Chelators of the DpT and BpT Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets – Iron, CDK2 and CDK9

S. Nekhai, D. Richardson, V. Gordeuk, 2010 .

Ferroportin Q248h, dietary iron, and serum ferritin in community African-Americans with low to high alcohol consumption.

S. Nekhai, V. Gordeuk, H. Tsukamoto, 2008, Alcoholism, clinical and experimental research.